Communiqués CV Sciences, Inc.

Actions

CVSI

US1266541028

Produits pharmaceutiques

Marché Fermé - OTC Markets 18:31:28 04/06/2026			Varia. 5j.	Varia. 1 janv.
0,0290 ^USD	+6,62%		+38,10%	-52,77%

13/08	Transcript : CV Sciences, Inc., Q2 2026 Earnings Call, Aug 13, 2026
02/06	Transcript : CV Sciences, Inc. - Shareholder/Analyst Call

Communiqués

13/08	CV Sciences, Inc. Reports Second Quarter-End 2026 Financial Results	AQ
12/08	CV Sciences Launches PlusHLTH.com, Expanding Its Consumer Platform Beyond Cannabinoids	AQ
11/08	CV Sciences, Inc. to Announce Second Quarter 2026 Results on August 13, 2026	AQ
26/06	CV Sciences Expands +PlusHLTH(TM) Portfolio with Personalized Wellness Solutions for Healthy Aging	AQ
14/05	CV Sciences, Inc. Reports First Quarter-End 2026 Financial Results	AQ
13/05	CV Sciences, Inc. To Announce First Quarter 2026 Results On May 14, 2026	AQ
26/03	CV Sciences, Inc. Reports Fiscal Year-End 2025 Financial Results	AQ
24/03	CV Sciences, Inc. To Announce Year End and Fourth Quarter 2025 Results On March 26, 2026	AQ
11/08/25	CV Sciences, Inc. To Announce Second Quarter 2025 Results On August 13, 2025	AQ
10/05/25	CV Sciences, Inc. to Announce First Quarter 2025 Results on May 14, 2025	AQ
28/03/25	CV Sciences, Inc. Reports Fiscal Year-End 2024 Financial Results	AQ
27/03/25	CV Sciences, Inc. Reports Fiscal Year-End 2024 Financial Results	AQ
26/03/25	CV Sciences Unveils Lunar Fox Food Co., an All-New Line of Plant-Based Foods	AQ
20/03/25	CV Sciences, Inc. To Announce Year End and Fourth Quarter 2024 Results On March 27, 2025	AQ
21/11/24	CV Sciences : Enters Into Definitive Agreement to Acquire Extract Labs Form 8 K	PU
21/11/24	CV Sciences, Inc. Enters Into Definitive Agreement to Acquire Extract Labs	PR
14/11/24	CV Sciences : Reports Third Quarter 2024 Financial Results Form 8 K	PU
14/11/24	CV Sciences, Inc. Reports Third Quarter 2024 Financial Results	PR
08/11/24	CV Sciences, Inc. To Announce Third Quarter 2024 Results On November 14, 2024	PR
13/08/24	CV Sciences, Inc. Reports Second Quarter 2024 Financial Results	PR
07/08/24	CV Sciences, Inc. To Announce Second Quarter 2024 Results On August 13, 2024	PR
14/05/24	CV Sciences, Inc. Reports First Quarter 2024 Financial Results	PR
14/05/24	CV SCIENCES, INC. ACQUIRES ELEVATED SOFTGELS, A FLEXIBLE, LOW-MOQ, NUTRACEUTICAL MANUFACTURER	PR
08/05/24	CV Sciences, Inc. To Announce First Quarter 2024 Results On May 14, 2024	PR
28/03/24	CV Sciences, Inc. Reports Fiscal Year-End 2023 Financial Results	PR